September 15, 2009 - Positron Corp. announced that the Ministry of Health and Long Term Care of Ontario, Canada is making positron emission tomography (PET) scanning a publicly insured health service available to cancer and cardiac patients under conditions where PET scans have been proven to be clinically effective. The Ministry of Health and Long Term Care (MOHLTC) has adopted an evidence-based approach to the introduction of PET imaging in the province for certain cancer and cardiac indications.

“Ontario, the largest province in Canada, introducing PET into their health system represents a significant opportunity for Positron to offer a cost effective general purpose scanner into a large socialized network,” said Joe Oliverio, chief technical officer of Positron. “We believe that the market for Positron’s Attrius PET scanner is potentially hundreds of units in a relatively short period of time. Health Canada’s approval of PET is further evidence that PET is the future of nuclear medicine. Positron plans to focus on marketing and selling its PET product throughout all Canadian provinces and estimates the entire market potential to be approximately 1,000 scanners.”

For more information: www.positron.com


Related Content

News | Radiopharmaceuticals and Tracers

Oct. 19, 2026 — Nuclidium AG, a clinical-stage radiopharmaceutical company, and NorthStar Medical Technologies, a global ...

Time October 19, 2026
arrow
News | Molecular Imaging

Editor's Note: This article has been updated to correct an earlier version. Oct. 15, 2026 — GE HealthCare has announced ...

Time October 16, 2026
arrow
News | Information Technology

October 6, 2026 – Clearsense has introduced a cloud-based medical image archive designed to reduce the cost of ...

Time October 07, 2026
arrow
News | Radiopharmaceuticals and Tracers

Oct. 5, 2026 — GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a U.S.-based CMO for PET ...

Time October 06, 2026
arrow
News | PET-MRI

Sept. 29, 2026 —Yale New Haven Hospital has installed a state-of-the-art positron emission tomography/magnetic resonance ...

Time October 05, 2026
arrow
News | Radiopharmaceuticals and Tracers

Aug. 30, 2026 — Bayer has announced the presentation of first detailed results from the Phase III REVEAL study, an ...

Time September 02, 2026
arrow
News | PET-MRI

June 10, 2026 — UTHealth Houston has launched a state-of-the-art PET/MRI imaging service, bringing together two advanced ...

Time June 12, 2026
arrow
News | Nuclear Imaging

June 1, 2026 — At the 2026 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, GE HealthCare will ...

Time June 02, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...

Time May 08, 2026
arrow
Subscribe Now